Patient guide

Hormone pills for fibroids, heavy periods or delaying periods: the risk of blood clots, DVT and stroke

How hormone pills and injections used for fibroids, heavy bleeding or delaying periods compare for blood clots, DVT and stroke. Who should be careful, warning signs, and safer options.

9 min readUpdated 5 Oct 2026Reviewed by Dr. Nagateja Bonala

Why this matters

Hormone medicines are often the first thing offered for fibroids, a bulky uterus, adenomyosis, heavy periods and irregular bleeding. Many women also use them to delay a period before a trip, wedding or exam. They can work well. But they are not all the same. A pill with estrogen, a progestin tablet and an injection that switches off the ovaries carry different risks. For many women, the risk that matters most is a blood clot.

This guide explains the differences in plain words: who should be most careful, which warning signs need urgent care, and what other options there are. It is general information and does not replace your own doctor's advice. Do not stop a medicine your doctor prescribed without talking to them first.

How the main medicines compare

The figures below come from large studies and trials. They describe groups of women. They cannot tell you exactly what will happen to you.

Hormone medicines used for fibroids, adenomyosis, heavy bleeding or delaying periods, and what is known about clots
MedicineClots, DVT and strokeWhat it is used for, and other points
Combined pills (estrogen plus progestin)About 3 times as likely to get a clot in a vein [1]. A higher chance of stroke from a clot too [3].Used for cycle control, heavy bleeding and period pain. The risk depends on the type of progestin and the dose of estrogen [1, 2].
Progestin-only pills, hormone IUDNo higher clot risk found [2, 4].Used for heavy bleeding, contraception and adenomyosis symptoms. The injection given every few months was linked to more clots in one study [4].
High-dose norethisterone tabletsClot risk at these doses is not as well studied. Serious clots have been reported [6]. Partly turned into estrogen in the body [5].Used to stop heavy bleeding or delay periods. A doctor should check your clot risk first [7].
GnRH agonists (such as leuprolide injections)No estrogen. The main problem is menopause-like side effects [11].Used to shrink fibroids or control bleeding, often before surgery. About 4 in 10 women had bad hot flashes in one trial [11].
GnRH antagonists with added hormones (elagolix, relugolix)They contain estradiol and norethindrone acetate. An expert review says the clot risk looks lower than with birth control pills, but you must be checked first [10].Used for fibroid bleeding. They worked well in trials [8, 9].
UlipristalNo estrogen. The main safety worry is the liver: liver injury has been reported [12].Used for fibroid bleeding and size. Mild liver problems were slightly more common than with GnRH injections in one study [12].

Pills with estrogen: how big is the clot and stroke risk?

Pills with estrogen make clots more likely, but for a healthy woman the chance is still small.

In a very large Danish study, about 3 in 10,000 women a year who did not use the pill had a clot in a vein. Among women on the pill, it was about 6 in 10,000. The risk was lower with lower estrogen doses, and lower the longer a woman had used the pill. Pills containing desogestrel, gestodene or drospirenone carried a higher risk than pills with levonorgestrel [2].

A UK study of more than 10,000 women who had a first clot found that women on combined pills were about 3 times as likely to have one. It was about 2.4 times for levonorgestrel pills and 2.6 times for norethisterone pills, but about 3.6 to 4.3 times for pills with desogestrel, gestodene, drospirenone or cyproterone [1].

Pills can also raise the chance of a stroke caused by a clot. In a Danish study of 1.6 million women, this kind of stroke happened in about 2 in 10,000 women a year overall. Pills with 30 to 40 micrograms of estrogen were linked to about 1.5 to 2.2 times that [3].

So the extra risk is real, but small for a healthy woman. It matters most when other risk factors are present (see below). That is why you should be checked before you start.

Norethisterone tablets to stop bleeding or delay periods

Norethisterone (also called norethindrone) tablets are one of the most common ways to delay a period or stop heavy bleeding. Because they are progestins, many people assume they are as safe as progestin-only pills. There is a catch.

In a study of women after menopause, the body turned a small part of norethisterone acetate into ethinylestradiol, the estrogen used in birth control pills. About 1 in 100 (0.7 to 1.0%) was changed this way. That works out to about 6 micrograms of ethinylestradiol for every milligram of norethisterone acetate [5]. At the 10 mg dose studied, that is roughly 60 micrograms, which is more than the 30 to 40 micrograms in many birth control pills [3]. This is a lab measurement. It does not tell us the actual clot risk for a woman taking the tablets.

How much these tablets raise the chance of a clot has not been measured as well as for birth control pills. Doctors have reported serious clots, including a clot in a vein of the brain in a young woman taking norethindrone acetate for abnormal bleeding [6]. Doctors have also called for safer prescribing for women at risk of clots [7].

In practice, short courses prescribed by a doctor are common, and many women take them without trouble. But they should be prescribed after your clot risk has been checked. They should not be bought over the counter and repeated month after month without a review.

GnRH injections and tablets: a different set of risks

GnRH medicines switch off the signal that tells the ovaries to make hormones. They do not contain estrogen. They stop periods and can shrink fibroids, but they can cause menopause-like effects such as hot flashes.

In a trial comparing ulipristal with a monthly leuprolide injection, bleeding was controlled in 89% of women on leuprolide. But about 4 in 10 of them (40%) had moderate to severe hot flashes, compared with about 1 in 10 on ulipristal [11].

Very low estrogen can also affect your bones. So newer treatments add back small amounts of estradiol and norethindrone acetate. In large trials, elagolix with these added hormones controlled heavy bleeding in about 7 out of 10 women (68.5% and 76.5%), compared with about 1 in 10 on dummy tablets [8]. Relugolix with added hormones worked for 71 to 73% of women, compared with 15 to 19% on dummy tablets, and it kept bone strength steady [9].

Because these combinations contain estrogen again, clots are a question. An expert review found that the trials and reports after launch had not shown a clear rise in clots with the relugolix combination, and that the risk looks lower than with birth control pills. It also said that women with clot risk factors must be chosen carefully [10].

Ulipristal has a different worry: liver injury has been reported [12]. Liver blood tests and careful selection matter.

Who should be especially careful

The CDC's 2024 guide to who can safely use which contraceptive method gives specific advice for women who have had a clot in the leg or lung, have a clotting disorder, are very overweight, or have had recent surgery [13]. Other things doctors commonly consider:

  • You or a close relative has had a clot, especially at a young age
  • Smoking, especially after age 35
  • Being very overweight
  • Not being able to move for a long time: after major surgery, in bed, or on a long journey
  • Migraine with aura (flashing lights or blind spots before a headache)
  • High blood pressure, diabetes or high cholesterol
  • Older age, because clot risk rises with age

Warning signs that need emergency care

Go to the nearest emergency department, or call an ambulance, if any of these happen while you are taking hormone medicines, or in the weeks afterwards.

  • A clot in the leg (DVT): pain, swelling, warmth or redness in one calf or thigh, usually on one side
  • A clot in the lung: sudden breathlessness, chest pain, a fast heartbeat, dizziness, or coughing up blood
  • A stroke: sudden weakness or numbness in the face, arm or leg, a drooping face, trouble speaking or understanding, sudden loss of vision, or a sudden, very bad headache

Safer ways to use hormones, and the alternatives

Hormones can be the right choice. These steps make them safer, and the alternatives are worth knowing about.

  • Tell your doctor everything first: earlier clots, family history, smoking, migraine with aura, your weight, and any recent or planned surgery.
  • Do not buy or repeat period-delaying tablets on your own. Ask for the lowest dose that works, for the shortest time.
  • Before any planned operation, tell the surgeon and anaesthetist that you take hormones. On long journeys, walk about and drink water.
  • If you need long-term control of heavy bleeding, ask about options with less estrogen. Progestin-only pills and hormone IUDs have not been linked to more clots [2, 4].
  • For fibroids, ask whether the cause can be treated, not only the bleeding. UFE blocks the blood supply to fibroids through a tiny puncture and keeps your uterus [15].
  • For adenomyosis, a small trial of 60 women found that blocking the uterine arteries (UAE) relieved symptoms better than dienogest tablets after 6 months. It worked for about 87% of women, compared with 50%. This was one short trial in one hospital, so larger studies are needed [14].

If you already have a clot or leg swelling

A clot in the leg needs prompt help. A Doppler ultrasound is usually the first test. Treatment depends on where the clot is and how serious it is. Tell the doctor treating you if you take hormone medicines. Do not stop or restart them without medical advice, because the right decision depends on your whole situation. See our guides on DVT symptoms and treatment, and on clot removal.

Frequently asked questions

Can I take norethisterone to delay my period?
Short courses prescribed by a doctor are common. But norethisterone is partly turned into estrogen in the body [5], serious clots have been reported [6], and doctors are advised to check your clot risk first [7]. Do not repeat it month after month without a review.
Do progestin-only pills cause DVT?
In a combined look at several studies, progestin-only pills did not raise the chance of a clot, and neither did hormone IUDs. The injection given every few months did (about 2.7 times as likely) [4].
Are GnRH injections safer than estrogen pills for clots?
They do not contain estrogen, so they do not carry the same estrogen-related clot worry. Their main effects are menopause-like [11]. Newer tablets add estradiol back, and an expert review says that clot risk still needs to be checked first [10].
How big is the clot risk from the pill?
In a Danish study, about 3 in 10,000 women a year had a clot without the pill, and about 6 in 10,000 with it [2]. It is a real increase, but still small for a healthy woman. Other risk factors add to it.
Should I stop my pill if I am worried?
Do not stop suddenly on your own, because heavy bleeding can come back and some conditions need continued treatment. Call your doctor to review it. If you have signs of a clot or stroke, go to emergency care straight away.
Can UFE replace hormone treatment for fibroids?
For many women with fibroid symptoms, UFE treats the fibroids themselves, so you may no longer need hormones to control the bleeding. Whether it suits you depends on your scans and your plans [15].

Get a rough idea of the cost

Choose what matters to you and we will show a guide. Nobody is committed to anything, and our team will never rush you.

Where would you like to stay?

Included for every patient

The same care and support whichever room you choose. Nothing here costs extra.

  • A dedicated care coordinator on WhatsApp before and after treatment
  • First available date and a time slot that suits you
  • Insurance approval and paperwork handled end to end
  • A planning call that walks your family through each step
  • Follow-up reviews and a 30-day check-in call
  • Reports and discharge summary shared digitally

By continuing you agree that Clinic Seven may call you about this estimate.

References

  1. Vinogradova Y, et al. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015;350:h2135. Read the source
  2. Lidegaard O, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890. Read the source
  3. Lidegaard O, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257-2266. Read the source
  4. Mantha S, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012;345:e4944. Read the source
  5. Kuhnz W, et al. In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women. Contraception. 1997;56:379-385. Read the source
  6. Rajput R, et al. Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report. J Obstet Gynaecol Can. 2008;30:680-683. Read the source
  7. Mansour D. Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care. 2012;38:148-149. Read the source
  8. Schlaff WD, et al. Elagolix for heavy menstrual bleeding in women with uterine fibroids. N Engl J Med. 2020;382:328-340. Read the source
  9. Al-Hendy A, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384:630-642. Read the source
  10. Douxfils J, et al. Venous thromboembolism risk associated with relugolix-estradiol-norethisterone acetate combination therapy. J Endocr Soc. 2026;10:bvaf190. Read the source
  11. Donnez J, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366:421-432. Read the source
  12. Yoon EL, Yuk JS. Use of ulipristal acetate and risk of liver disease: a nationwide cohort study. J Clin Endocrinol Metab. 2021;106:1773-1782. Read the source
  13. Nguyen AT, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73:1-126. Read the source
  14. Refaat R, et al. Uterine artery embolization versus dienogest for symptomatic adenomyosis: a randomized controlled trial of short-term efficacy. Eur J Radiol. 2026;196:112712. Read the source
  15. Society of Interventional Radiology. Uterine fibroids: patient information. Read the source

Want to discuss your options?

Speak with the Clinic Seven team.

NAGATEJAVascular & Interventional Radiology